Progesterone transdermal - Transdermal Delivery Solutions

Drug Profile

Progesterone transdermal - Transdermal Delivery Solutions

Alternative Names: Progesterone spray - Transdermal Delivery Solutions; Progesterone TDS®

Latest Information Update: 27 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Transdermal Delivery Solutions Corp
  • Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Menopausal syndrome; Premenstrual syndrome

Most Recent Events

  • 27 May 2016 Progesterone is still in non-clinical development for Menopausal and Premenstrual syndrome (Company website - May 2016)
  • 09 May 2002 Preclinical trials in Menopausal syndrome in USA (Transdermal)
  • 09 May 2002 Preclinical trials in Premenstrual syndrome in USA (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top